Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 18 de 18
Filter
Add more filters










Publication year range
1.
Undersea Hyperb Med ; 45(1): 83-87, 2018.
Article in English | MEDLINE | ID: mdl-29571236

ABSTRACT

Neuropsychiatric sequelae have been reported in 15%-45% of survivors of carbon monoxide (CO) poisoning. Hyperbaric oxygen (HBO2) therapy reduces the incidence of cognitive and neurological a dysfunction. The efficacy of providing HBO2 beyond the first one to two days after initial insult is unknown. However, some evidence exists for the benefit of this treatment. We report on treating a patient 14 months after CO injury, who responded with markedly improved neurologic status. A 27-year-old scholar was found comatose due to CO poisoning (carboxyhemoglobin = 31.7%). He received five acute HBO2 treatments. After discharge, he developed chorea, Parkinsonism, dystonia, memory loss, slowed processing speed and verbal fluency, leaving him disabled. After the patient reached a clinical plateau, HBO2 was tried again at 90 minutes at 2.4 ATA plus air breaks. Neuropsychological testing was performed at baseline and after each 20 HBO2 cycles, five of which were performed during the period from 14-22 months after CO exposure. After the first 20 treatments, Parkinsonism and dystonia improved. After 40 sessions, further improvements were seen on mental speed, verbal fluency, and fine motor movements. The outcome following 100 treatments was that the patient regained independence, including the ability to drive and to become gainfully employed. Our case calls into question the concept that HBO2 therapy has no role during the chronic phase of CO brain injury. Randomized clinical trials should be considered to evaluate the therapeutic efficacy of HBO2 in patients with neurological sequelae following CO injury.


Subject(s)
Carbon Monoxide Poisoning/complications , Hyperbaric Oxygenation/methods , Neurocognitive Disorders/therapy , Recovery of Function , Adult , Dystonia/etiology , Dystonia/therapy , Humans , Hyperbaric Oxygenation/statistics & numerical data , Independent Living , Male , Neurocognitive Disorders/etiology , Neuropsychological Tests , Parkinsonian Disorders/etiology , Parkinsonian Disorders/therapy , Retreatment/methods , Retreatment/statistics & numerical data , Suicide, Attempted , Time Factors , Treatment Outcome
3.
Mov Disord Clin Pract ; 3(3): 282-284, 2016.
Article in English | MEDLINE | ID: mdl-27430001

ABSTRACT

BACKGROUND: Diaphragmatic myoclonus is a rare disorder of repetitive diaphragmatic contractions, acknowledged to be a spectrum that includes psychogenic features. Electromyography has been the diagnostic tool most commonly used in the literature. METHODS: To test if we could perform a noninvasive technique to delineate the diaphragm as the source of abnormal movements and demonstrate distractibility and entrainability, we used B-mode ultrasound in a patient with diaphragmatic myoclonus. RESULTS: Ultrasound imaging clearly delineated the diaphragm as the source of her abdominal movements. We were able to demonstrate entrainability of the diaphragm to hand tapping to a prescribed rhythm set by examiner. CONCLUSION: We recommend the use of ultrasound as a noninvasive, convenient diagnostic tool for further studies of diaphragmatic myoclonus. We agree with previous findings that diaphragmatic myoclonus may be a functional movement disorder, as evidenced by distractibility and entrainability demonstrated on real-time video with ultrasonography.

4.
Neurobiol Aging ; 43: 174-9, 2016 07.
Article in English | MEDLINE | ID: mdl-27255827

ABSTRACT

The temporal discrimination threshold (TDT) is the shortest interstimulus interval at which a subject can perceive successive stimuli as separate. To investigate the effects of aging on TDT, we studied tactile TDT using the method of limits with 120% of sensory threshold in each hand for each of 100 healthy volunteers, equally divided among men and women, across 10 age groups, from 18 to 79 years. Linear regression analysis showed that age was significantly related to left-hand mean, right-hand mean, and mean of 2 hands with R-square equal to 0.08, 0.164, and 0.132, respectively. Reliability analysis indicated that the 3 measures had fair-to-good reliability (intraclass correlation coefficient: 0.4-0.8). We conclude that TDT is affected by age and has fair-to-good reproducibility using our technique.


Subject(s)
Aging/psychology , Discrimination, Psychological , Sensory Thresholds , Adolescent , Adult , Aged , Female , Humans , Male , Middle Aged , Time Perception/physiology , Young Adult
6.
Neural Plast ; 2016: 3920298, 2016.
Article in English | MEDLINE | ID: mdl-26904298

ABSTRACT

Introduction. Paired associative stimulation (PAS) is an established technique to investigate synaptic plasticity in the human motor cortex (M1). Classically, to induce long-term depression- (LTD-) or long-term potentiation-like effects in the human M1, studies have used low frequency and long duration trains of PAS. In the present study, we explored an LTD-like effect using very short duration and low frequency of PAS10 ms protocols in human M1. Methods. Six protocols of low frequency PAS10 ms (ranging from 0.2 Hz to 1 Hz) were investigated with very short durations of 1 and 2 minutes stimulation. Six healthy volunteers were included in each protocol. We obtained motor-evoked potentials from right abductor pollicis brevis muscle before and after applying PAS10 ms up to 30 minutes. After we found PAS10 ms protocol which induced an LTD-like effect, we tested that protocol on additional 5 subjects. Results. One-way repeated-measures ANOVA showed that only the group of 1-minute stimulation of 0.25 Hz induced an LTD-like effect. When adding the additional subjects, the effect remained and lasted for 30 minutes. Conclusion. Low frequency and very short duration of PAS10 ms potentially induced an LTD-like effect in human M1. With further verification, this method might be useful for research relating to synaptic plasticity by reducing the duration of study and minimizing subject discomfort.


Subject(s)
Long-Term Synaptic Depression , Motor Cortex/physiology , Neuronal Plasticity , Transcranial Magnetic Stimulation/methods , Adult , Evoked Potentials, Motor , Female , Humans , Male
7.
Ann Clin Transl Neurol ; 2(6): 707-10, 2015 Jun.
Article in English | MEDLINE | ID: mdl-26125045

ABSTRACT

Psychogenic dystonia is a challenging entity to diagnose and treat because little is known about its pathophysiology. We describe two cases of psychogenic dystonia who underwent deep brain stimulation when thought to have organic dystonia. The intraoperative microelectrode recordings in globus pallidus internus were retrospectively compared with those of five patients with known DYT1 dystonia using spontaneous discharge parameters of rate and bursting, as well as movement-related discharges. Our data suggest that simple intraoperative neurophysiology measures in single subjects do not differentiate psychogenic dystonia from DYT1 dystonia.

8.
J Neurol Neurosurg Psychiatry ; 85(9): 987-93, 2014 Sep.
Article in English | MEDLINE | ID: mdl-24487380

ABSTRACT

Sensory tricks are various manoeuvres that can ameliorate dystonia. Common characteristics are well known, but their variety is wide, sensory stimulation is not necessarily the critical feature, and their physiology is unknown. To enumerate the various forms of sensory tricks and describe their nature, research findings and theories that may elucidate their neurophysiologic mechanism, we reviewed the literature pertaining to sensory tricks, including variants like motor tricks, imaginary tricks, forcible tricks and reverse sensory tricks. On the basis of this information, we propose a new classification of sensory tricks to include its variants. We highlight neurophysiologic evidence suggesting that sensory tricks work by decreasing abnormal facilitation. We tie this with established dystonia pathogenesis and postulate that sensory tricks decrease abnormally increased facilitation to inhibition ratios in the dystonic brain. It appears worthwhile for patients to search for possible sensory tricks.


Subject(s)
Dystonia/therapy , Sensory Aids , Dystonia/physiopathology , Electromyography , Humans , Neuroimaging , Physical Stimulation
10.
Mov Disord Clin Pract ; 1(4): 383-385, 2014 Dec.
Article in English | MEDLINE | ID: mdl-27066521

ABSTRACT

Botulinum toxin is a mainstay therapy for dystonia. Formulations available are three types of botulinumtoxinA and one type of botulinumtoxinB.1 Antibodies can develop against the toxin, leading to treatment failure. IncobotulinumtoxinA (Xeomin; Merz Pharmaceuticals GmbH, Frankfurt, Germany) is differentiated from other types of botulinumtoxinA preparations by being free from complexing proteins, speculated to make the product less antigenic.2.

12.
Age Ageing ; 41(2): 273-4, 2012 Mar.
Article in English | MEDLINE | ID: mdl-21795275

ABSTRACT

A 60-year-old man diagnosed clinically with Becker's muscular dystrophy 20 years ago by another physician presented with gradually progressive proximal muscle weakness since teenage years. Family history revealed a strong paternal familial inheritance pattern of similar distribution of weakness-face, forearm flexion, knee extension and foot dorsiflexion. Work-ups revealed B12 deficiency and allele 1 deletion in fascioscapulohumeral muscular dystrophy (FSHD) DNA testing. FSHD is the third most common muscular dystrophy. Clinical diagnosis is made from the distinctive pattern of weakness, autosomal-dominant inheritance, and confirmed by genetic testing. This case strongly demonstrates the importance of a thorough and careful clinical evaluation even in a case with a long standing diagnosis.


Subject(s)
Diagnostic Errors , Muscular Dystrophy, Duchenne/diagnosis , Muscular Dystrophy, Facioscapulohumeral/diagnosis , Chromosomes, Human, Pair 4 , Genetic Predisposition to Disease , Genetic Testing , Heredity , Humans , Male , Middle Aged , Muscle Weakness/genetics , Muscular Dystrophy, Facioscapulohumeral/genetics , Muscular Dystrophy, Facioscapulohumeral/physiopathology , Muscular Dystrophy, Facioscapulohumeral/therapy , Pedigree , Phenotype , Predictive Value of Tests , Time Factors
14.
Rev Neurol Dis ; 8(3-4): e121-2, discussion e135-7, 2011.
Article in English | MEDLINE | ID: mdl-22249567

ABSTRACT

A 62-year-old woman with no known psychiatric illness had a 1.5-year history of progressive personality and language changes, leading to a loss of functional independence. Laboratory results revealed elevated autoimmune antibodies. She did not improve on high-dose steroid therapy and continued to deteriorate to her death, 2.5 years after symptom onset.


Subject(s)
Disease Progression , Frontotemporal Dementia/diagnosis , Language Disorders/diagnosis , Personality Disorders/diagnosis , Female , Frontotemporal Dementia/complications , Humans , Language Disorders/complications , Middle Aged , Personality Disorders/complications
SELECTION OF CITATIONS
SEARCH DETAIL
...